BMEA240719C2500
- 3.10
- 0.000.00%
Biomea Fusion Newsroom
Scotiabank Maintains Biomea Fusion(BMEA.US) With Buy Rating, Maintains Target Price $21
Biomea Fusion, Inc. (BMEA): Why Did Analysts Give This Biotech Penny Stock a Moderate Buy Rating?
Rodman & Renshaw Downgrades Biomea Fusion(BMEA.US) to Hold Rating, Cuts Target Price to $9
H.C. Wainwright Maintains Biomea Fusion(BMEA.US) With Buy Rating, Cuts Target Price to $15
Express News | HC Wainwright & Co. Reiterates Buy on Biomea Fusion, Maintains $15 Price Target
Biomea Fusion, Inc. (BMEA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Biomea Fusion Stock Down 48% But Insiders Still In US$17k Profit
Franco Valle Bought 42% More Shares In Biomea Fusion
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
12 Health Care Stocks Moving In Thursday's Intraday Session
Biomea Fusion(BMEA.US) Officer Buys US$55,361.08 in Common Stock
Truist Cuts Biomea Fusion to Hold, Cites Clinical Hold Uncertainty
This Cleveland-Cliffs Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Truist Financial Maintains Biomea Fusion(BMEA.US) With Hold Rating, Maintains Target Price $5
Truist Financial Initiates Biomea Fusion(BMEA.US) With Hold Rating, Announces Target Price $5
Biomea Fusion Downgraded to Hold at Truist Securities With No Price Target Following Clinical Hold Placed by FDA Last Week
Express News | Biomea Fusion Shares Down 1.9% Premarket After Truist Securities Cuts to Hold From Buy
Express News | Biomea Fusion Inc : Truist Securities Cuts to Hold From Buy
Sector Update: Health Care Stocks Higher Late Afternoon
Top Midday Decliners